Essential role for proteinase-activated receptor-2 in arthritis
Authors:
- William R. FerrellWFWilliam R. Ferrell
- John C. LockhartJLJohn C. Lockhart
- Elizabeth B. KelsoEKElizabeth B. Kelso
- Lynette DunningLDLynette Dunning
- Robin PlevinRPRobin Plevin
- Stephen E. MeekSMStephen E. Meek
- Andrew J.H. SmithASAndrew J.H. Smith
- Gary D. HunterGHGary D. Hunter
- John S. McLeanJMJohn S. McLean
- Frances McGarryFMFrances McGarry
- Robert RamageRRRobert Ramage
- Lu JiangLJLu Jiang
- 1 January 2003
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 111 (1) , 35-41
Abstract
Using physiological, pharmacological, and gene disruption approaches, we demonstrate that proteinase-activated receptor-2 (PAR-2) plays a pivotal role in mediating chronic inflammation. Using an adjuvant monoarthritis model of chronic inflammation, joint swelling was substantially inhibited in PAR-2–deficient mice, being reduced by more than fourfold compared with wild-type mice, with virtually no histological evidence of joint damage. Mice heterozygous for PAR-2 gene disruption showed an intermediate phenotype. PAR-2 expression, normally limited to endothelial cells in small arterioles, was substantially upregulated 2 weeks after induction of inflammation, both in synovium and in other periarticular tissues. PAR-2 agonists showed potent proinflammatory effects as intra-articular injection of ASKH95, a novel synthetic PAR-2 agonist, induced prolonged joint swelling and synovial hyperemia. Given the absence of the chronic inflammatory response in the PAR-2–deficient mice, our findings demonstrate a key role for PAR-2 in mediating chronic inflammation, thereby identifying a novel and important therapeutic target for the management of chronic inflammatory diseases such as rheumatoid arthritis.Keywords
This publication has 18 references indexed in Scilit:
- Agonists of Proteinase-Activated Receptor 2 Induce Cytokine Release and Activation of Nuclear Transcription Factor κB in Human Dermal Microvascular Endothelial CellsJournal of Investigative Dermatology, 2002
- Proteinase-activated Receptor-2-mediated Activation of Stress-activated Protein Kinases and Inhibitory κB Kinases in NCTC 2544 KeratinocytesJournal of Biological Chemistry, 2001
- Basolateral proteinase‐activated receptor (PAR‐2) induces chloride secretion in M‐1 mouse renal cortical collecting duct cellsThe Journal of Physiology, 1999
- Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat pawBritish Journal of Pharmacology, 1999
- Ligand Cross-reactivity within the Protease-activated Receptor FamilyJournal of Biological Chemistry, 1996
- Two Genetically Separable Steps in the Differentiation of Thymic EpitheliumScience, 1996
- Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.Proceedings of the National Academy of Sciences, 1994
- Regulation by hypoxia of endothelin‐1‐stimulated phospholipase D activity in sheep pulmonary artery cultured smooth muscle cellsBritish Journal of Pharmacology, 1994
- Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imagingNeuroscience, 1993
- Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cellsGene, 1988